Nielsen A M, Stenderup J, Wandall J H, Bonnevie O
Scand J Gastroenterol. 1985 Dec;20(10):1236-8. doi: 10.3109/00365528509089282.
The reduction in gastric acid secretion by 10 mg and 30 mg omeprazole was studied in 12 patients with ulcer disease in a randomized, double-blind, two-way balanced crossover study. A standardized pentagastrin test was performed before the study and 24 h after each treatment period of 6 days. Treatment was followed by a washout period of 7 days. Omeprazole, 30 mg/day, significantly reduced basal acid output (BAO) by 90% and pentagastrin-stimulated acid output (PAO) by 45% (p less than 0.01), whereas BAO and PAO were not significantly reduced by omeprazole, 10 mg/day.
在一项随机、双盲、双向平衡交叉研究中,对12例溃疡病患者进行了研究,以观察10毫克和30毫克奥美拉唑对胃酸分泌的减少作用。在研究前以及每个为期6天的治疗期结束后24小时,进行了标准化的五肽胃泌素试验。治疗后有7天的洗脱期。30毫克/天的奥美拉唑显著降低基础酸排量(BAO)90%,五肽胃泌素刺激酸排量(PAO)45%(p小于0.01),而10毫克/天的奥美拉唑对BAO和PAO没有显著降低作用。